UPDATE - Barclays initiates coverage on Calumet Specialty Products Partners (Nasdaq: CLMT) with an Equalweight rating. PT $22.

Barclays analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE